Cibus shares rise 10.64% premarket after signing LOI with Interoc for HT rice commercialization in Latin America.

Cibus surged 10.64% in premarket trading following the announcement of a non-binding Letter of Intent (LOI) with Interoc to commercialize herbicide-tolerant (HT) rice traits in Latin America. The LOI outlines plans to launch HT1 and HT3 traits in Ecuador and Colombia in 2027, with expansion into Peru, Central America, and the Caribbean. This strategic partnership builds on a 2024 material transfer agreement, marking a shift from R&D to market execution and revenue generation. The news signals progress in Cibus’ commercialization pipeline and highlights potential market share growth in key rice-producing regions, addressing critical weed management challenges for farmers. The premarket rally reflects investor optimism about the agreement’s long-term revenue potential and the company’s ability to scale its gene-editing technologies in collaboration with Interoc.